<table id="ID698" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 5. Clinically-Significant Drug Interactions with Sertraline Hydrochloride</caption>
<col width="16%"></col>
<col width="84%"></col>
<tbody>
<tr>
<td align="left" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Monoamine </content>
<content stylecode="bold">Oxidase </content>
<content stylecode="bold">Inhibitors </content>
<content stylecode="bold">(</content>
<content stylecode="bold">MAOIs</content>
<content stylecode="bold">)</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Impact</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">The concomitant use of SSRIs including sertraline hydrochloride and MAOIs increases the risk of serotonin syndrome.
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Intervention</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Sertraline hydrochloride is contraindicated in patients taking MAOIs, including MAOIs such as linezolid or intravenous methylene blue 
            
    
     <content stylecode="italics">[</content>
<content stylecode="italics">See </content>
<content stylecode="italics">Dosage </content>
<content stylecode="italics">and </content>
<content stylecode="italics">Administration </content>
<content stylecode="italics">(</content>
<content stylecode="italics">2</content>
<content stylecode="italics">.</content>
<content stylecode="italics">5</content>
<content stylecode="italics">), </content>
<content stylecode="italics">Contraindications </content>
<content stylecode="italics">(</content>
<content stylecode="italics">4</content>
<content stylecode="italics">), </content>
<content stylecode="italics">Warnings </content>
<content stylecode="italics">and </content>
<content stylecode="italics">Precautions </content>
<content stylecode="italics">(</content>
<content stylecode="italics">5</content>
<content stylecode="italics">.</content>
<content stylecode="italics">2</content>)].
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Examples</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">selegiline, tranylcypromine, isocarboxazid, phenelzine, linezolid, methylene blue
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Pimozide</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Impact</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Increased plasma concentrations of pimozide, a drug with a narrow therapeutic index, may increase the risk of QT prolongation and ventricular arrhythmias.
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Intervention</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Concomitant use of pimozide and sertraline hydrochloride is contraindicated 
            
    
     <content stylecode="italics">[</content>
<content stylecode="italics">See </content>
<content stylecode="italics">Contraindications </content>
<content stylecode="italics">(</content>
<content stylecode="italics">4</content>)].
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Other </content>
<content stylecode="bold">Serotonergic </content>
<content stylecode="bold">Drugs</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Impact</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">The concomitant use of serotonergic drugs with sertraline hydrochloride increases the risk of serotonin syndrome.
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Intervention</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Monitor patients for signs and symptoms of serotonin syndrome, particularly during treatment initiation and dosage increases. If serotonin syndrome occurs, consider discontinuation of sertraline hydrochloride and/or concomitant serotonergic drugs 
            
    
     <content stylecode="italics">[</content>
<content stylecode="italics">See </content>
<content stylecode="italics">Warnings </content>
<content stylecode="italics">and </content>
<content stylecode="italics">Precautions </content>
<content stylecode="italics">(</content>
<content stylecode="italics">5</content>
<content stylecode="italics">.</content>
<content stylecode="italics">2</content>)].
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Examples</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">other SSRIs, SNRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John’s Wort
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Drugs </content>
<content stylecode="bold">that </content>
<content stylecode="bold">Interfere </content>
<content stylecode="bold">with </content>
<content stylecode="bold">Hemostasis </content>
<content stylecode="bold">(</content>
<content stylecode="bold">antiplatelet </content>
<content stylecode="bold">agents </content>
<content stylecode="bold">and </content>
<content stylecode="bold">anticoagulants</content>
<content stylecode="bold">)</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Impact</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">The concurrent use of an antiplatelet agent or anticoagulant with sertraline hydrochloride may potentiate the risk of bleeding.
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Intervention</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Inform patients of the increased risk of bleeding associated with the concomitant use of sertraline hydrochloride and antiplatelet agents and anticoagulants. For patients taking warfarin, carefully monitor the international normalized ratio 
            
    
     <content stylecode="italics">[</content>
<content stylecode="italics">See </content>
<content stylecode="italics">Warnings </content>
<content stylecode="italics">and </content>
<content stylecode="italics">Precautions </content>
<content stylecode="italics">(</content>
<content stylecode="italics">5</content>
<content stylecode="italics">.</content>
<content stylecode="italics">3</content>)].
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Examples</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">aspirin, clopidogrel, heparin, warfarin
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Drugs </content>
<content stylecode="bold">Highly </content>
<content stylecode="bold">Bound </content>
<content stylecode="bold">to </content>
<content stylecode="bold">Plasma </content>
<content stylecode="bold">Protein</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Impact</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Sertraline hydrochloride is highly bound to plasma protein. The concomitant use of sertraline hydrochloride with another drug that is highly bound to plasma protein may increase free concentrations of sertraline hydrochloride or other tightly-bound drugs in plasma 
            
    
     <content stylecode="italics">[</content>
<content stylecode="italics">See </content>
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Pharmacology </content>
<content stylecode="italics">(</content>
<content stylecode="italics">12</content>
<content stylecode="italics">.</content>
<content stylecode="italics">3</content>
<content stylecode="italics">)].</content>
<br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Intervention</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Monitor for adverse reactions and reduce dosage of sertraline hydrochloride or other protein-bound drugs as warranted.
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Examples</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">warfarin
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Drugs </content>
<content stylecode="bold">Metabolized </content>
<content stylecode="bold">by </content>
<content stylecode="bold">CYP2D6</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Impact</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Sertraline hydrochloride is a CYP2D6 inhibitor 
            
    
     <content stylecode="italics">[</content>
<content stylecode="italics">See </content>
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Pharmacology </content>
<content stylecode="italics">(</content>
<content stylecode="italics">12</content>
<content stylecode="italics">.</content>
<content stylecode="italics">3</content>)]. The concomitant use of sertraline hydrochloride with a CYP2D6 substrate may increase the exposure of the CYP2D6 substrate.
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Intervention</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Decrease the dosage of a CYP2D6 substrate if needed with concomitant sertraline hydrochloride use. Conversely, an increase in dosage of a CYP2D6 substrate may be needed if sertraline hydrochloride is discontinued.
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Examples</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">propafenone, flecainide, atomoxetine, desipramine, dextromethorphan, metoprolol, nebivolol, perphenazine, thoridazine, tolterodine, venlafaxine
            
    
     <br/>
</td>
</tr>
<tr>
<td align="left" colspan="2" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Phenytoin</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Clinical </content>
<content stylecode="italics">Impact</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Phenytoin is a narrow therapeutic index drug. Sertraline hydrochloride may increase phenytoin concentrations.
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Intervention</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Monitor phenytoin levels when initiating or titrating sertraline hydrochloride. Reduce phenytoin dosage if needed.
            
    
     <br/>
</td>
</tr>
<tr>
<td align="center" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="italics">Examples</content>
<content stylecode="italics">:</content>
<content stylecode="italics">
<br/>
</content>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">phenytoin, fosphenytoin
            
    
     <br/>
</td>
</tr>
</tbody>
</table>